Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoral and Certican in heart transplant recipients
NCT00098007Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Primary completion
- Jan 2007
- Countries
- 8
01
Overview
A Phase 3 trial of everolimus in heart transplantation, sponsored by Novartis. Started Aug 2004; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT00098007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098007.